Polyunsaturated Fatty Acid Supplementation in Athletes: A Systematic Review

Basit Öğe Kaydı
dc.contributor.authorFernandes, Matheus Santos de Sousa
dc.contributor.authorda Costa, Jonathan Manoel
dc.contributor.authorBadicu, Georgian
dc.contributor.authorSantos, Gabriela Carvalho Jurema
dc.contributor.authorSilva, Deyvison Guilherme Martins
dc.contributor.authorLagranha, Claudia Jacques
dc.contributor.authorYagin, Fatma Hilal
dc.date.accessioned2026-04-04T13:19:02Z
dc.date.available2026-04-04T13:19:02Z
dc.date.issued2024
dc.departmentİnönü Üniversitesi
dc.description.abstractBackground: This study aims to summarize the evidence regarding the effects of polyunsaturated fatty acids (PUFAs) supple-mentation on both amateur and professional athletes. Objective: The aim is to elucidate the impacts of PUFAs supplementation on physical performance, inflammatory response, biochemical profile, anthropometric/body composition, and performance outcomes in athletes. Methods: Articles published up to December 2023 were retrieved from databases including Cochrane Library, PubMed/Medline, Scopus, and Embase. Selected articles met eligibility criteria and quality methodology. Data on inflammatory response, biochemical markers, anthropometric/body composition, and neuromuscular indicators were extracted. Results: Twenty-one studies were included in this systematic review. PUFAs supplementation resulted in decreased levels of certain inflammatory markers (interferon-gamma, interleukin 1, prostaglandin E2, and tumor necrosis factor alpha). However, no significant differences were observed in interleukin 4, 6, 8, 10, and matrix metalloproteinase 9. Additionally, there were no differences in glycemic (glucose and insulin) and lipid metabolism (high density lipoprotein (HDL)) cholesterol, low density lipoprotein (LDL), triglycerides). A reduction in reactive oxygen species levels was noted. No significant differences were found in muscle fatigue markers and anthropometry. Some performance parameters (neuromuscular and aerobic) improved following supplementation, including performance on the Yo-Yo distance test, resting energy expenditure, exercise time to exhaustion, and maximum oxygen consumption/maximum heart rate. Conclusion: Supplementation with PUFAs (600–3150 mg) in athletes led to reductions in inflammation and oxidative stress markers, as well as improvements in specific aerobic performance parameters. However, no significant effects were observed on glycemic and lipid profiles, anthropometric profiles, or body composition. © 2024 The Author(s).
dc.identifier.doi10.23812/j.biol.regul.homeost.agents.20243806.367
dc.identifier.endpage4623
dc.identifier.issn0393-974X
dc.identifier.issue6
dc.identifier.scopus2-s2.0-85204745643
dc.identifier.scopusqualityN/A
dc.identifier.startpage4607
dc.identifier.urihttps://doi.org/10.23812/j.biol.regul.homeost.agents.20243806.367
dc.identifier.urihttps://hdl.handle.net/11616/108107
dc.identifier.volume38
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherBiolife Publisher
dc.relation.ispartofJournal of Biological Regulators and Homeostatic Agents
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250329
dc.subjectathletes
dc.subjectperformance
dc.subjectphysical activity
dc.subjectpolyunsaturated fatty acids
dc.subjectsports nutrition
dc.titlePolyunsaturated Fatty Acid Supplementation in Athletes: A Systematic Review
dc.typeReview

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu